Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TGTX
#1040
TG Therapeutics, Inc. - Common Stock
53.9
3
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.21%
Monthly Change
+0.88%
6 month change
+83.50%
Year Change
+83.62%
Previous Close
55.7
2
Open
53.9
3
Low
53.9
3
High
53.9
3
Volume
115
Markets
US Stock Market
Healthcare
Biotechnology
TGTX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
140.59 M
142.82 M
146.36 M
154.42 M
157.07 M
159.69 M
153.07 M
Valuation ratios
Enterprise value
6.79 B
2.48 B
1.66 B
2.64 B
4.79 B
4.93 B
8.8 B
Price to earnings ratio
—
—
-7.92
189.33
200.67
10.76
20.34
Price to sales ratio
—
—
562.55
10.83
14.67
7.81
11.14
Price to cash flow ratio
—
—
-8.89
-80.56
-119.11
-194.24
481.26
Price to book ratio
—
—
26.73
15.77
21.7
7.43
3.65
Enterprise value to EBITDA ratio
-24.92
-7.23
-8.73
126.58
114.11
39.93
64.46
Profitability ratios
Return on assets %
-0.45
-0.92
-1.02
0.04
0.04
0.42
0
Return on equity %
-0.54
-1.47
-3.39
0.08
0.11
0.69
0.01
Return on invested capital %
-1 649.24
-2 168.43
-1 554.62
145.45
108.67
271.62
8.13
Gross margin %
100
100
100
93.95
88.3
83.66
82.86
Operating margin %
-180 K
-5 154.28
-6 924.2
8.83
12.74
20.01
9.02
EBITDA margin %
-179.28 K
-5 130.75
-6 839.5
8.92
12.76
20.02
9.04
Net margin %
-183.8 K
-5 204.08
-7 121.54
5.42
7.11
72.56
3.24
Liquidity ratios
Quick ratio
—
—
—
5.18
5.03
3.29
3.72
Current ratio
6.99
5.06
3.16
5.92
6.25
4.1
4.27
Inventory turnover
—
—
—
0.35
0.51
0.8
0.3
Asset turnover
0
0.01
0.01
0.89
0.73
0.58
0.15
Solvency ratios
Debt to assets ratio
0.01
0.18
0.37
0.3
0.42
0.23
0.45
Debt to equity ratio
0.06
0.29
1.21
0.62
1.1
0.38
1.23
Long term debt to total assets ratio
0.05
0.18
0.37
0.3
—
-0
—
Long term debt to total equity ratio
0.06
0.29
1.21
0.63
—
-0.01
—
Per share metrics
Operating cash flow per share
—
—
-1.3
-0.21
-0.25
-0.15
0.12
EBIT per share
—
—
-1.42
0.14
0.26
0.76
0.85
EBITDA per share
—
—
-1.41
0.14
0.26
0.76
0.85
Total debt per share
—
—
0.53
0.67
1.52
1.52
4.74
Cash per share
—
—
1.29
1.46
1.94
1.24
3.89
Net current asset value per share
—
—
1.24
2.14
3.53
3.91
7.28
Tangible book value per share
—
—
0.43
1.08
1.39
4.01
3.84
Working capital per share
—
—
0.85
1.78
2.97
2.96
5.58
Book value per share
—
—
0.43
1.08
1.39
4.01
3.84
News
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX)
TGTX Stock Outperforms 95% of Stocks. Here's Why.
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors (NASDAQ:TGTX)
Hospital Operator Tenet Healthcare Leads 13 To IBD Top Stock Screens
Dow Jones Futures: Market Rally Repairs Some Damage; Nvidia, CrowdStrike, Warsh In Focus
TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics
Stock Market Rally Powers Ahead; SpaceX, Palantir, Sandisk Are Key Earnings Movers: Weekly Review
Amazon Stock, Exelixis And CrowdStrike Among 17 New Stocks On IBD Watchlists
TG Therapeutics: Why I'm Staying Long After The Q2 Selloff (NASDAQ:TGTX)
TGTX Q2 Earnings Lag, Sales Rise Y/Y, 2026 View Raised, Stock Down
Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble
Here's What Key Metrics Tell Us About TG Therapeutics (TGTX) Q2 Earnings